The short version
13 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Melphalan Hydrochloride
Melphalan Hydrochloride · Kit · Intravenous · Sagent Pharmaceuticals
NDC 25021-0258-61 · 1 KIT in 1 CARTON * 10 mL in 1 VIAL * 10 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$200.00
Reported to Texas DSHS · 2026 annual filing · Sagent Pharmaceuticals
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 50 MG
$104.898
HCPCS J9245 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Hepzato
Regulatory
- Application
- ANDA209826
- TE code
- AP
- Approval date
- May 28, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Melphalan Hydrochloride (Kit)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dr.Reddy's Laboratories Inc | Jul 15, 2026 | Sep 3, 2026 | |
| Arthur Group LLC | Jul 15, 2026 | Sep 2, 2026 | |
| Avenacy Inc. | Jul 15, 2026 | Sep 2, 2026 | |
| BPI Labs LLC | Jul 15, 2026 | Sep 2, 2026 | |
| Camber Pharmaceuticals, Inc. | Jul 15, 2026 | Sep 2, 2026 | |
| Fosun Pharma USA Inc | Jul 15, 2026 | Sep 2, 2026 | |
| Fresenius Kabi USA, LLC | Jul 15, 2026 | Sep 2, 2026 | |
| Gland Pharma Limited | Jul 15, 2026 | Sep 2, 2026 | |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Jul 15, 2026 | Sep 2, 2026 | |
| Meitheal Pharmaceuticals Inc. | Jul 15, 2026 | Sep 2, 2026 | |
| Mylan Institutional LLC | Jul 15, 2026 | Sep 2, 2026 | |
| Qilu Pharmaceutical Co., Ltd. | Jul 15, 2026 | Sep 2, 2026 | |
| Sagent Pharmaceuticals | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Melphalan Hydrochloride — NDC 25021-0258-61," retrieved September 3, 2026, https://drugdashboards.com/drug/25021025861.
Free to cite with attribution — see how the data is put together.